Clinical Drug Development & Investigations
Oliver Grundmann, PhD (he/him/his)
Director & Clinical Professor, Medicinal Chemistry
Univ of Florida
Kirsten Smith, PhD
Postdoctoral Fellow, Real-World Assessment, Prediction & Treatment Unit
National Inst on Drug Abuse
Jack Henningfield, PhD
Vice President, Research, Health Policy & Abuse Liability, Pinney Associates Inc and Professor, Behavioral Biology
Johns Hopkins Univ School of Medicine Prediction & Treatment Unit, National Inst on Drug Abuse Intramural Research Program
This Symposium is interdisciplinary for all healthcare professions and across work settings for academia, industry, regulatory agencies and clinical entities, and will be useful for graduate students, postdoctoral fellows/trainees and early-stage career professionals, as well as advanced professionals working in preclinical and clinical drug development and practice settings.
Chair & Faculty: Oliver Grundmann, PhD (he/him/his) – Univ of Florida
Faculty: Jack Henningfield, PhD – Johns Hopkins Univ School of Medicine Prediction & Treatment Unit, National Inst on Drug Abuse Intramural Research Program
Chair & Faculty: Kirsten E. Smith, PhD – National Inst on Drug Abuse